Hematopoietic development from human induced pluripotent stem cells. - Wikidata - awgldk - TriplyDB

Hematopoietic development from human induced pluripotent stem cells.

Hematopoietic development from human induced pluripotent stem cells.

http://www.wikidata.org/entity/Q33770557

about

HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells Advances in cellular technology in the hematology field: What have we learned so far?A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma Reconstructing blood from induced pluripotent stem cells.Interactions between Cdx genes and retinoic acid modulate early cardiogenesis.Harnessing the potential of induced pluripotent stem cells for regenerative medicine.Caudal genes in blood development and leukemia.Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.Targeting Wnt pathways in disease.The hematopoietic system in the context of regenerative medicine.Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development.Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.Pluripotent stem cell-derived natural killer cells for cancer therapy.Potential clinical applications for human pluripotent stem cell-derived blood components.Standardization of pluripotent stem cell cultures for toxicity testing.Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways.Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?Mesodermal and hematopoietic differentiation from ES and iPS cells.The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells.Therapeutic Implications of Newly Identified Stem Cell Populations From the Skin Dermis.Stem cell therapy for inflammatory bowel disease.Human fetal liver: an in vitro model of erythropoiesis.Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.Variation in mesodermal and hematopoietic potential of adult skin-derived induced pluripotent stem cell lines in mice.Effect of increased HoxB4 on human megakaryocytic development.Patch clamp apply in cardiomyocytes derived from patient's iPS cells for individual anticancer therapy.Globin phenotype of erythroid cells derived from human induced pluripotent stem cells.[In vitro generation of blood red cells from stem cells: a sketch of the future].Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states.

P2860

Q24299118-E6846142-0AC4-407B-B186-85453B2A217F Q26853179-2E8604F6-6897-4399-BCEE-456DF595D5A8 Q28477450-B079A7A4-CD2B-417E-8530-4DEBB645FBFD Q28482184-51332BC4-ED47-4F9C-82BB-B01C9D6A193C Q33559521-F3949205-E057-400A-8C48-2BBEB7689127 Q33806378-25B8F62C-9672-4A26-965D-B34F3BD587D0 Q34175573-C392D371-8A4A-4EE4-A9F2-40D1E03FC500 Q34175967-12039287-B359-443E-B2F0-52202CD14122 Q34182222-643ADC60-8DF9-40CB-B1BA-3E5EE1899137 Q34294578-20381DC4-9FAB-4DFE-A3DC-260252E44884 Q34382978-E305EB1D-E3D1-47D0-91B6-A224657F0746 Q34852041-7A13B466-0295-4433-8EB7-8139A5B23301 Q34990691-152AB6E1-88C9-44E1-A821-C3875545EFCA Q35082744-C5FAADA2-173D-4964-B6A8-0CB2B8B61E88 Q35944308-C42CCE41-25BF-40A7-A86D-B47355D77A26 Q36506697-86D5BEBB-996E-41FD-B681-EBCC63C230D1 Q36627127-80F96833-4789-4F13-B9A1-834D0133869D Q36670949-30D301D7-44CA-4EDF-8CF9-C8A8B11E863B Q36829190-BD9A4EF5-C56D-4CA0-88C9-F05E4F1BF5F6 Q37772900-44E51970-59EE-45AA-A0E0-AA0179181101 Q37783804-CADE78A9-5C55-4A49-B673-E1F09AE1352E Q37857709-28316171-38E3-4522-BDDE-DA1BEC411773 Q37976119-71ED1466-59E4-4350-B313-CD38A092BE19 Q37980722-7749845A-5BEB-494E-96C9-450B32D9DC2D Q37995010-6D3E22EE-4BC1-4E27-B438-680B2C4A2D8A Q38017612-504E40D8-4EFC-4145-9892-58938889965A Q38030196-6ED778E3-ED4A-42DB-9F07-4CC4E355BB87 Q38116641-43B5924C-D35B-4F72-B4FA-3A26E6796EDD Q38223850-3D3D10EC-8275-4FC0-B908-15EC43F6E6BD Q38331002-E01BD744-FCD2-4CF2-84A3-0E829AE82550 Q38559513-22DB1030-86F4-4303-A965-29906BA380C5 Q39063423-3FD4C56C-C726-4AE0-A92A-0841A8044F90 Q39572724-0EB81C19-DA9C-48E9-B9AF-853EB79DD7E7 Q39685330-385136B6-A700-4C08-B74A-C1BA3E915BE8 Q42205262-D90ED706-D7A3-4FED-BFE8-8A2A7A50F586 Q42857534-A3747162-9AED-498C-A12D-2728511DED84 Q50237862-4FDDA070-7EF4-4A29-B299-BA398D83396E Q50618088-0B17597E-DC66-40E1-8256-2A60AB8CAD66

P2860

Hematopoietic development from human induced pluripotent stem cells.

http://www.wikidata.org/entity/Q33770557

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hematopoietic development from human induced pluripotent stem cells.

@ast

Hematopoietic development from human induced pluripotent stem cells.

@en

type

label

Hematopoietic development from human induced pluripotent stem cells.

@ast

Hematopoietic development from human induced pluripotent stem cells.

@en

altLabel

Hematopoietic development from human induced pluripotent stem cells

@en

prefLabel

Hematopoietic development from human induced pluripotent stem cells.

@ast

Hematopoietic development from human induced pluripotent stem cells.

@en

P1433

Q33770557-C3E2BDDE-A498-46C1-9E8F-DF8C0282C137

P1476

Q33770557-12AB6361-EF75-44F7-8ECC-C7896C18FB23

P2093

Q33770557-107EB996-DD57-431F-803A-231CDF00B742

Q33770557-21CC8765-0B3C-4215-9E7B-3A703E51CED8

Q33770557-6114A3E0-B557-4939-B2E5-957D87F9373A

Q33770557-71AFEC2C-0760-4A95-B413-4CBF56BBDDAC

Q33770557-AE249EC8-9EAF-46C5-8D9B-39E32941ACF6

P2860

Q33770557-0B7EB851-F51B-47D0-A69A-6F896066EA7B

Q33770557-0C31CD97-F07A-4516-86D4-DF4AE22AA13E

Q33770557-0C3BB6DC-DF78-4BFA-B024-697251259732

Q33770557-0D13DDBA-476D-4BB2-83B2-A933EB417C77

Q33770557-15FA21D8-C76B-473D-AAE3-7D5925430C92

Q33770557-18F74EBE-F526-4E5E-AA2D-244FC8FAAB31

Q33770557-21BED6C5-24AB-45FA-ADFE-9E9D827D90D9

Q33770557-448A048B-66DA-41E9-AFC5-0454A95BA52E

Q33770557-4D21183F-AC98-4D8D-8672-56E77DE51950

Q33770557-5E0F886D-F03B-44D6-BD7B-8D64F7A9B48E

P304

Q33770557-FAC26E0F-BC0A-478D-A992-60D04E192D44

P31

Q33770557-4DF29C65-8DEC-4949-85FC-6A7D56D6D6FD

P356

Q33770557-E3D1B05D-92BA-4125-83DF-A9D223D98983

P407

Q33770557-CA51D0A5-8BF9-4CE6-B59B-EDA72966BBF0

P433

Q33770557-F8B8D0C7-F1AE-42F3-8AD5-9AB4F9AA6A3B

P478

Q33770557-36149773-483F-4DEF-BEF4-84AEE6670260

P50

Q33770557-8221F66E-FE22-4637-8806-7A181736EC81

Q33770557-A1B39BAD-D465-46D5-AD87-A9F46E19AC1F

P577

Q33770557-D10DBA98-9AFE-4BB9-8E79-95B0C2CDC7A8

P5875

Q33770557-CDB4340C-62CB-4218-A7A5-43EE12CEA398

P698

Q33770557-4AA977D0-3DE5-458F-BBDC-B2CB982419EA

P921

Q33770557-86E5E443-50B4-4918-96DC-4ACA1946CC25

P932

Q33770557-506FEC65-5EB2-4769-BC99-3560575DCDE1

P356

J.1749-6632.2009.04606.X

P1433

Annals of the New York Academy of Sciences

P1476

Hematopoietic development from human induced pluripotent stem cells.

@en

P2093

In-Hyun Park

http://www.w3.org/2001/XMLSchema#string

Lothar Kanz

http://www.w3.org/2001/XMLSchema#string

Matthias Grauer

http://www.w3.org/2001/XMLSchema#string

Nina I Niebuhr

http://www.w3.org/2001/XMLSchema#string

Tamara Riedt

http://www.w3.org/2001/XMLSchema#string

P2860

Embryonic stem cell differentiation: emergence of a new era in biology and medicine

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

Disease-specific induced pluripotent stem cells

Induced pluripotent stem cell lines derived from human somatic cells

Establishment in culture of pluripotential cells from mouse embryos

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Generation of germline-competent induced pluripotent stem cells

Reprogramming of human somatic cells to pluripotency with defined factors

Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells

P304

219-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2009.04606.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1176

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Lengerke

George Q. Daley

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26862704

http://www.w3.org/2001/XMLSchema#string

P698

19796250

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells

P932

2849804

http://www.w3.org/2001/XMLSchema#string